A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'
Eur J Cancer
.
2021 Apr:147:185-186.
doi: 10.1016/j.ejca.2021.01.003.
Epub 2021 Feb 12.
Authors
Frédéric Dumont
1
,
Christophe Passot
2
,
Jean-Luc Raoul
3
Affiliations
1
Department of Surgical Oncology, Institut de Cancérologie de L'Ouest, Saint-Herblain, France. Electronic address: frederic.dumont@ico.unicancer.fr.
2
Oncopharmacology, Pharmacogenetics, Institut de Cancérologie de L'Ouest, Angers, France.
3
Department of Medical Oncology, Institut de Cancérologie de L'Ouest, Saint-Herblain, France.
PMID:
33589368
DOI:
10.1016/j.ejca.2021.01.003
No abstract available
Publication types
Letter
Comment
MeSH terms
Aerosols
Gastrointestinal Neoplasms*
Humans
Laparoscopy*
Oxaliplatin
Peritoneal Neoplasms* / drug therapy
Substances
Aerosols
Oxaliplatin